First-dose ChAdOx1 and BNT162b2 COVID-19 vaccines and thrombocytopenic, thromboembolic and hemorrhagic events in Scotland

C R Simpson, T Shi, E Vasileiou, S V Katikireddi, S Kerr, E Moore, C McCowan, U Agrawal, S A Shah, L D Ritchie, J Murray, J Pan, D T Bradley, S J Stock, R Wood, A Chuter, J Beggs, H R Stagg, M Joy, R S M TsangS de Lusignan, R Hobbs, R A Lyons, F Torabi, S Bedston, M O'Leary, A Akbari, J McMenamin, C Robertson, A Sheikh

Research output: Contribution to journalArticlepeer-review

13 Citations (Scopus)

Fingerprint

Dive into the research topics of 'First-dose ChAdOx1 and BNT162b2 COVID-19 vaccines and thrombocytopenic, thromboembolic and hemorrhagic events in Scotland'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds